CIT sustains in part and remands in part Commerce's 2022-23 AD review of glycine from India

The U.S. Court of International Trade, in Slip Op. 26-112, Court No. 25-00081, sustained in part and remanded in part Commerce's final determination in the 2022-23 administrative review of the antidumping duty order on glycine from India, covering June 1, 2022, to May 31, 2023. The case was brought by Kumar Industries and Bajaj Healthcare Limited; Deer Park Glycine, LLC was defendant-intervenor. Commerce had applied facts otherwise available with an adverse inference to Kumar and assigned Bajaj, a non-selected respondent, the simple average of Kumar's and Avid Organics' dumping margins.